Alkermes Plc news

   Watch this stock
Showing stories 1 - 10 of about 104   

Articles published

ALKS 63.15 +1.98 (3.24%)
price chart
Alkermes Plc Receives Consensus Recommendation of "Hold" from Analysts (NASDAQ ...
Alkermes Plc logo Shares of Alkermes Plc (NASDAQ:ALKS) have been given a consensus rating of “Hold” by the fourteen ratings firms that are covering the stock, MarketBeat reports.
Alkermes plc (NASDAQ:ALKS) Price Target Update  Insider Trading Report
Large Inflow of Money Witnessed in Alkermes plc  Money Flow Index
Alkermes plc Short Interest Update
The short interest in Alkermes plc (NASDAQ:ALKS) has declined from 8,883,008 on July 31,2015 to 8,612,476 on August 14,2015.
Shane Cooke Sold 18000 shares of Alkermes Plc (NASDAQ:ALKS) in an Insider Trade  OctaFinance.com
Alkermes plc (NASDAQ:ALKS) Given $37-$81 PT Range  Markets Daily
Alkermes plc Announces Sale of Gainesville, GA Manufacturing Facility to Recro ...
DUBLIN--(BUSINESS WIRE)--Alkermes plc (NASDAQ:ALKS) today announced that it has entered into a definitive agreement to sell its manufacturing facility in Gainesville, GA, the manufacturing and royalty revenue associated with products manufactured at ...
Alkermes divests Gainesville facility  Atlanta Business Chronicle
Alkermes plc Reports First Quarter 2015 Financial Results
Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio.
Alkermes' (ALKS) CEO Richard Pops on Q1 2015 Results - Earnings Call ...  Seeking Alpha
James Frates, SVP & CFO – Alkermes plc of Alkermes Plc (NASDAQ:ALKS) Just Sold ...
The Alkermes Plc (NASDAQ:ALKS) 63.15 +1.98 3.24% 's SVP & CFO - Alkermes plc, James Frates, an insider made a sale of - 10,000 Alkermes Plc.'s shares, based on $68.0 per share. The company's shares had a value of around $679,747 US Dollars.
Alkermes plc Price Target Update
Alkermes plc (NASDAQ:ALKS): The stock price is expected to reach $ 67.38 in the short term. The number of analysts agreeing with this consensus is 8. The higher estimate for the short term price target is at $81 while the lower estimate is at $37.
Alkermes Plc (ALKS) Downgraded From Hold to Sell
"We rate ALKERMES PLC (ALKS) a SELL. This is driven by some concerns, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the stocks we cover.
Why Gordon Pugh Sold 32977 Shares of Alkermes Plc (NASDAQ:ALKS)?
The SVP - COO & CRO - Alkermes - Inc. of Alkermes Plc (NASDAQ:ALKS) 57.53 +0.88 1.55% , Gordon Pugh, has just unloaded - 32,977 shares of the firm he's supervising and operating - coming to an aggregate transaction of $2,081,248 USD (this based ...
Insider Selling: Alkermes Plc CFO Sells 10000 Shares of Stock (ALKS)  Dakota Financial News
Alkermes Plc (NASDAQ:ALKS)'s Insider Robert Breyer Sells 2000 Shares
Robert Breyer is the director of Alkermes Plc (NASDAQ:ALKS) 60.07 +2.54 4.42% . He a few days ago sold 2,000 shares in the -listed Alkermes Plc. with the trade value amounting to approx. $139,220 U.S Dollars. The number is according to the filed price ...
Alkermes Plc. (ALKS) Files Form 4 Insider Selling : Gordon G Pugh Sells ...  Insider Trading Report
Earnings Watch: Alkermes plc (NASDAQ:ALKS)  Markets Daily
Alkermes PLC (NASDAQ:ALKS) in Spotlight
[Business Wire] Alkermes PLC (NASDAQ:ALKS)(TREND ANALYSIS) announced that data from studies of the company's pipeline of central nervous system (CNS) drug candidates in schizophrenia and depression, including ALKS 3831, aripiprazole lauroxil ...
Stock To Watch: Alkermes (ALKS) In Perilous Reversal  TheStreet.com